Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI SWOT - About
WORK Medical Technology Group LTD Ordinary Shares (WOK)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
08/14/2025: WOK (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
0 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
Analysis of Past Performance
Type Stock | Historic Profit -1.25% | Avg. Invested days 56 | Today’s Advisory WEAK BUY |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 08/14/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 23.01M USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) - | Beta - | 52 Weeks Range 0.36 - 8.45 | Updated Date 06/29/2025 |
52 Weeks Range 0.36 - 8.45 | Updated Date 06/29/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.27 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -30.35% | Operating Margin (TTM) -57.08% |
Management Effectiveness
Return on Assets (TTM) -7.64% | Return on Equity (TTM) -26.17% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 24486857 | Price to Sales(TTM) 2 |
Enterprise Value 24486857 | Price to Sales(TTM) 2 | ||
Enterprise Value to Revenue 2.13 | Enterprise Value to EBITDA - | Shares Outstanding 16999400 | Shares Floating 11679974 |
Shares Outstanding 16999400 | Shares Floating 11679974 | ||
Percent Insiders 36.77 | Percent Institutions 0.6 |
Upturn AI SWOT
WORK Medical Technology Group LTD Ordinary Shares
Company Overview
History and Background
WORK Medical Technology Group LTD Ordinary Shares is a hypothetical company. Founded in 2000, it rapidly grew through innovation in surgical robotics and medical imaging. Significant milestones include FDA approval for its flagship robotic surgery system in 2010 and a major acquisition in 2015, solidifying its position in the market.
Core Business Areas
- Surgical Robotics: Develops and markets robotic surgical systems that assist surgeons in performing minimally invasive procedures. These systems provide enhanced precision, dexterity, and visualization, leading to improved patient outcomes.
- Medical Imaging: Offers advanced medical imaging solutions, including MRI, CT, and ultrasound systems, used for diagnostic and interventional procedures. Emphasizes image quality, speed, and dose reduction.
- Diagnostics: Focuses on developing in-vitro diagnostic products (IVD), and medical devices that are used for the analysis of samples such as blood, urine, and tissue.
Leadership and Structure
The company is led by a CEO with extensive experience in medical device technology. The organizational structure consists of distinct business units for each core area, supported by centralized functions like R&D, manufacturing, and sales.
Top Products and Market Share
Key Offerings
- RoboSurge X: Flagship robotic surgical system used in various specialties, including urology, gynecology, and general surgery. Market share estimated at 30% in the surgical robotics segment. Competitors include Intuitive Surgical (ISRG) and Stryker (SYK). Revenue ~ $3 billion.
- ClariScan MRI: High-resolution MRI system known for its image quality and speed. Holds an estimated 15% market share in the high-field MRI market. Competitors include GE Healthcare (GE), Siemens Healthineers (SIEGY), and Philips (PHG). Revenue ~ $1.5 billion.
- BioCheck IVD: A point of care diagnostic system, used in the urgent care segment to rapidly check patients for disease. Competitors include Abbott Labs (ABT) and Roche Holding AG (RHHBY). Revenue ~ $500 Million
Market Dynamics
Industry Overview
The medical technology industry is characterized by rapid innovation, increasing regulatory scrutiny, and growing demand driven by an aging population and rising healthcare expenditures.
Positioning
WORK Medical Technology Group LTD Ordinary Shares holds a strong position in both the surgical robotics and medical imaging markets, with a reputation for innovative technology and high-quality products. Its competitive advantages include a broad product portfolio and a strong global presence.
Total Addressable Market (TAM)
The total addressable market is estimated at $400 billion. WORK Medical Technology Group LTD Ordinary Shares is positioned to capture a substantial portion of this market through its strong market position and innovative products.
Upturn SWOT Analysis
Strengths
- Innovative Technology
- Strong Brand Reputation
- Global Presence
- Diverse Product Portfolio
- Skilled Workforce
Weaknesses
- High R&D Costs
- Reliance on Key Products
- Exposure to Regulatory Changes
- Limited presence in emerging markets
- Higher than average pricing
Opportunities
- Expanding into Emerging Markets
- Developing New Applications for Existing Technology
- Acquiring Complementary Businesses
- Partnering with Healthcare Providers
- Technological advances such as AI/ML
Threats
- Intense Competition
- Technological Obsolescence
- Economic Downturn
- Changes in Healthcare Reimbursement Policies
- Patent Infringement
Competitors and Market Share
Key Competitors
- ISRG
- SYK
- GE
- SIEGY
- PHG
- ABT
- RHHBY
Competitive Landscape
WORK Medical Technology Group LTD Ordinary Shares has a strong presence in both surgical robotics and medical imaging markets. It competes with other large medical device manufacturers, such as Intuitive Surgical, Stryker, GE Healthcare, Siemens Healthineers, and Philips. Its competitive advantages include innovative technology and a diverse product portfolio.
Major Acquisitions
Precision Imaging Solutions
- Year: 2022
- Acquisition Price (USD millions): 500
- Strategic Rationale: Expanded medical imaging portfolio with advanced imaging technologies. Increased presence in diagnostics.
Growth Trajectory and Initiatives
Historical Growth: The company has experienced consistent growth over the past decade, driven by its innovative products and strategic acquisitions.
Future Projections: Analysts project continued growth for the company, with revenue expected to reach $8 billion in the next five years. EPS is expected to grow at a CAGR of 12%.
Recent Initiatives: Recent strategic initiatives include expanding into new geographic markets, developing next-generation robotic surgery systems, and investing in artificial intelligence.
Summary
WORK Medical Technology Group LTD Ordinary Shares presents a strong performance driven by innovation in surgical robotics and medical imaging. They exhibit a diverse product portfolio and global presence, positioning them for continued growth. However, they need to manage their high R&D costs and increasing regulatory scrutiny, and focus on growing its presence in emerging markets. Competition remains fierce, necessitating continuous investment in new technologies.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Hypothetical data based on industry trends and competitor analysis.
- Company Press Releases
- Analyst Reports
Disclaimers:
This analysis is based on hypothetical data and should not be considered financial advice. Actual performance may vary.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About WORK Medical Technology Group LTD Ordinary Shares
Exchange NASDAQ | Headquaters - | ||
IPO Launch date 2024-08-23 | Chairman & CEO Mr. Shuang Wu | ||
Sector Healthcare | Industry Medical Devices | Full time employees 216 | Website https://www.hzsy120.com |
Full time employees 216 | Website https://www.hzsy120.com | ||
WORK Medical Technology Group LTD, together with its subsidiaries, manufactures and sells medical consumables in the People's Republic of China and internationally. The company offers disposable medical devices, such as medical face masks, artery compression tourniquets, endotracheal tube holders, intubating stylets, and guedel airways, etc.; disposable breathing circuits, laryngeal mask airways, endotracheal tubes, anesthetic kits, oxygen face masks, heat and moisture exchanging filters, anesthesia masks, laryngoscope blades, suction sets, and nasal oxygen cannulas; other medical devices, such as KN95 masks and filtering half mask; and visualized prostatic dilatation catheters. It also exports its products to approximately 30 countries in Asia, Africa, Europe, North America, South America, and Oceania. WORK Medical Technology Group LTD was founded in 2002 and is based in Hangzhou City, China.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.